Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series

Glioblastoma multiforme (GBM) remains an incurable condition, associated with a median survival time of 15 months with best standard of care and 5-year survival rate of <10%. We report on four GBM patients on combination treatment regimens that included oncolytic virus (OV) immunotherapy, who ach...

Descripción completa

Detalles Bibliográficos
Autores principales: Gesundheit, Benjamin, Ben-David, Eliel, Posen, Yehudit, Ellis, Ronald, Wollmann, Guido, Schneider, E. Marion, Aigner, Karl, Brauns, Lars, Nesselhut, Thomas, Ackva, Ingrid, Weisslein, Christine, Thaller, Arno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241257/
https://www.ncbi.nlm.nih.gov/pubmed/32477944
http://dx.doi.org/10.3389/fonc.2020.00702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241257/
https://www.ncbi.nlm.nih.gov/pubmed/32477944
http://dx.doi.org/10.3389/fonc.2020.00702

Ejemplares similares